Vanda Asks Full Fed. Circ. To Review Axed Sleep Med Patents
Vanda Pharmaceuticals Inc. has urged the entire Federal Circuit to weigh in on a panel's recent affirmance that prior art invalidates as obvious four patents on brand-name sleep drug Hetlioz, contending...To view the full article, register now.
Already a subscriber? Click here to view full article